Clinical Trials Directory

Trials / Completed

CompletedNCT02092402

Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Örebro University, Sweden · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the effect of fecal microbiota transplantation (FMT) on the symptoms of irritable bowel syndrome (IBS) patients.

Conditions

Interventions

TypeNameDescription
OTHERFecal transplantation

Timeline

Start date
2013-09-01
Primary completion
2016-11-01
Completion
2019-06-01
First posted
2014-03-20
Last updated
2019-08-28

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT02092402. Inclusion in this directory is not an endorsement.

Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome (NCT02092402) · Clinical Trials Directory